Patients Specialty medication access hinges on a 48-hour window The vast majority of healthcare providers (HCPs) say that PA-related delays directly harm patient outcomes.
Patients Approval is not access: Pilots’ real test is implementation A medicine can be nationally recommended and still be difficult to access if local systems are not ready to identify, offer, deliver, and monitor it.
Digital Sponsored Technology solutions for smarter clinical trials: Inventus In an exclusive video interview, Steve Sanghera – CEO and co-founder of Inventus – sat down with pharmaphorum to discuss the company's journey & ethos
Patients Innovation can transform NHS care, but scaling is the missin... Innovation is already improving care across the NHS, but we are not yet consistently delivering at scale for the benefit of patients
Digital Smaller, smarter devices for global trial diversity Consumer device giants are surging into the healthcare arena to make devices cheaper, more compact, and easier for patients to use.
Patients Sponsored 12 Questions with Kim Innes Kim Innes is General Manager of Teva UK. She has more than 30 years’ experience across the pharmaceutical industry.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
